Senior Clinical Research Physician & Safety Leader

100 Eli Lilly and Company; Indianapolis (IN); On-site; USD 201,000 - 361,000; Full time

Benefits offered by this job

401(k) eligibility

Pension program

Vacation benefits

Medical/dental/vision benefits

Job summary

Lilly is seeking a Clinical Research Physician for GPS Medical to lead safety oversight and medical assessments across lifecycle stages of assigned products. The role requires MD/DO board eligibility, strong clinical expertise, and the ability to collaborate with product teams, regulatory bodies, and external stakeholders.

Key responsibilities include medical leadership in pharmacovigilance activities, safety data evaluation, and coordinating with cross-functional partners to ensure robust risk

Qualifications

• Fluent in English with highly effective written and verbal skills.
• Strong clinical/diagnostic skills and ability to translate medical data for cross-functional teams.
• Willing to engage in domestic and international travel as needed.

Responsibilities

• Provide medical assessment decisions for safety questions in collaboration with cross-functional partners.
• Lead GPS Medical activities and safety oversight for assigned products.
• Represent GPS Medical in internal and external stakeholder discussions and regulatory interactions.
• Support QA/Compliance and training within the GPS Medical team.

Skills

Fluent English

Clinical/diagnostic skills

Travel flexibility

Interpersonal skills

Education

Medical Doctor or Doctor of Osteopathy

Job description

Lilly is seeking a Clinical Research Physician for GPS Medical to lead safety oversight and medical assessments across lifecycle stages of assigned products. The role requires MD/DO board eligibility, strong clinical expertise, and the ability to collaborate with product teams, regulatory bodies, and external stakeholders.

Key responsibilities include medical leadership in pharmacovigilance activities, safety data evaluation, and coordinating with cross-functional partners to ensure robust risk